fda compounding glp-1 enforcement news today 2025 September 15, 2025: Telehealth company must stop implying its compounded GLP -1 is FDA-approved, warns – Partnership for Safe Medicines Managing Compounded GLP-1 Medications: A
Description
Consequently, GLP-1 that is secreted by intestinal L-cells is rapidly degraded by dipeptylpeptidase-4 (DPP-4) in the endothelium of the portal circulation and in the liver, as well as by a soluble circulating moiety of DPP-4
Understanding the science behind this phenomenon helps patients make informed decisions about personalized treatment
Backed by Science
Providing high quality, affordable health care to families and individuals covered by government programs for over 30 years.
Clinically studied for greater weight loss than GLP-1 alone
GLP-1 receptor agonists remain blockbuster drugs for weight management for people with overweight or obesity
